|
Volumn 35, Issue 12, 1996, Pages 803-806
|
Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
ANTIINFECTIVE AGENT;
ANTIULCER AGENT;
BISMUTH CITRATE;
CLARITHROMYCIN;
DRUG DERIVATIVE;
FURAZOLIDONE;
LANSOPRAZOLE;
OMEPRAZOLE;
ORGANOMETALLIC COMPOUND;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
DUODENUM ULCER;
DYSPEPSIA;
FEMALE;
HELICOBACTER INFECTION;
HELICOBACTER PYLORI;
HUMAN;
MALE;
MICROBIOLOGY;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
ANTI-BACTERIAL AGENTS;
ANTI-ULCER AGENTS;
CLARITHROMYCIN;
DRUG THERAPY, COMBINATION;
DUODENAL ULCER;
DYSPEPSIA;
FEMALE;
FURAZOLIDONE;
HELICOBACTER INFECTIONS;
HELICOBACTER PYLORI;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
ORGANOMETALLIC COMPOUNDS;
|
EID: 0030310602
PISSN: 05781426
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|